Novo Nordisk A/S
Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait
Packages of the weight-loss drug Wegovy from the pharmaceutical company Novo Nordisk lie on the sales counter in a Danish pharmacy. Stefan Trumpf | Picture Alliance | Getty Images Danish pharmaceutical giant Novo Nordisk is set to launch its hugely popular Wegovy obesity drug in Germany this month, but it could be some time before […]
Read More
Morgan Stanley sees profound shift in diabetes treatment boosting opportunity for weight-loss drugs
Morgan Stanley analysts said they are seeing a profound shift in the way diabetes is being treated, with doctors intensifying the focus on weight management, which is accelerating the uptake of GLP-1 medications. What’s more, the analysts anticipate that over the next 24 months, this weight-centric approach will start to spread to other health complications […]
Read More
Morgan Stanley picks ‘particularly large conviction’ worldwide shares it suggests the rest of the marketplace is lacking
Morgan Stanley has named various get-rated world wide shares it expects to conquer the sector. In a notice to investors, it named shares following inquiring analysts to pick from a listing exactly where they have “specially significant conviction that the industry is not pricing the conquer” in phrases of the recent earnings bulletins. The lender […]
Read More
What investors need to know about weight loss medicines and suicide risk
Investors would be forgiven if talk of a potential suicide risk associated with a new class of diabetes and weight loss drugs led to skittishness last week. Prior attempts to treat overweight or obese patients with medications were often plagued with side effects and drug recalls. Those earlier medications often didn’t seem like the results […]
Read More
Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Friday said it will acquire Versanis, a privately held obesity drug maker, for up to $1.93 billion to boost the pharmaceutical giant’s weight loss treatment portfolio. Eli Lilly agreed to pay Versanis shareholders in […]
Read More
Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Mike Segar | Reuters Uninsured Americans pay nearly $98 on average for a vial of Eli Lilly‘s generic insulin, even after the company pledged to cut the product’s list price to $25 per vial, […]
Read More
EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images The European Union’s drug regulator on Tuesday said it has broadened an investigation into the risk of suicidal thoughts and self-injury among patients taking Novo Nordisk‘s Ozempic, […]
Read More
Stocks producing the most important moves midday: Shutterstock, Newell Manufacturers, Zillow and a lot more
Rafael Henrique | Lightrocket | Getty Images Check out out the firms making headlines in midday trading. Shutterstock — Shares of the inventory impression, video clip and audio provider jumped 10% right after Shutterstock introduced a 6-calendar year, expanded partnership with OpenAI, the maker of ChatGPT. Newell Makes — Shares of the customer products corporation […]
Read More
Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Only around one-third of patients prescribed weight loss drugs such as Novo Nordisk‘s blockbuster injection Wegovy continued to take it a year later — but total health-care costs […]
Read More
European regulator to evaluation pounds-reduction prescription drugs adhering to stories of suicidal thoughts
Deals of the bodyweight-decline drug Wegovy from the pharmaceutical business Novo Nordisk lie on the income counter in a Danish pharmacy. Stefan Trumpf | Image Alliance | Getty Visuals The European Medicines Agency claimed Monday it would undertake a critique into a quantity of medication applied to handle obesity and diabetic issues immediately after it […]
Read More